accountin 2009 to treat patients with advanced kidney cancer who didn���t benefit from Sutent or Nexavar from Bayer AG and Onyx Pharmaceuticals Inc. Afinitor blocks a protein known as mTOR that some cancer cells require to grow and multiply. The drug is also...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to Novartis Drug Wins FDA Panel Backing for Jobs���s Cancer Type
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account